NCT00714922 Comparison of Photorefractive Keratectomy (PRK) and Sub-Bowman's Keratomileusis (SBK) Status COMPLETED Phase NA
NCT00714610 Serum Metal Ion Concentrations Following Primary Hip Arthroplasty Status COMPLETED Phase N/A
NCT00714350 Evaluation of Information Displays A Paper & Pencil, Computer, Simulator, and ICU Based Study Status COMPLETED Phase N/A
NCT00714012 Evaluation of Information Displays-A Paper, Computer and Simulator Based Study Status COMPLETED Phase N/A
NCT00713856 Comparison of Conventional and Custom Photorefractive Keratectomy (PRK) Status COMPLETED Phase NA
NCT00708721 Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Status TERMINATED Phase PHASE1/PHASE2
NCT00708526 Improved Patient Recovery After Anesthesia With Hypercapnia Hyperpnoea Status COMPLETED Phase NA
NCT00708448 Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients Status COMPLETED Phase PHASE1
NCT00707343 [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors Status COMPLETED Phase PHASE1
NCT00707278 Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma Status COMPLETED Phase PHASE1
NCT00707213 FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients Status TERMINATED Phase PHASE1
NCT00707174 Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna Status COMPLETED Phase NA
NCT00707161 Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma Status TERMINATED Phase PHASE2
NCT00706810 Combination of Hydroxyurea and Verapamil for Refractory Meningiomas Status COMPLETED Phase PHASE2
NCT00694096 Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response Status COMPLETED Phase PHASE1
NCT00693212 Further Studies of Attention Deficit Disorder - Residual Type (RT) Status COMPLETED Phase PHASE3